Latest News and Press Releases
Want to stay updated on the latest news?
-
MONTRÉAL, 06 févr. 2026 (GLOBE NEWSWIRE) -- Groupe Prime Drink Corp. (CSE: PRME) (« Prime » ou la « Société ») est heureuse d'annoncer qu'elle a obtenu des licences exclusives de Prime...
-
MONTREAL, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) is pleased to announce that it has secured exclusive licenses from Prime Capital...
-
REHOVOT, Israel and SHANGHAI, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Evogene Ltd. (Nasdaq/TASE: EVGN) ("Evogene"), a pioneering computational chemistry company specializing in generative design of small...
-
February 4, 2026 Biodexa Announces Exclusive License of Otsuka’s OPB-171775, a potent Phase 1 ready Molecular Glue for GIST Novel Mechanism of Action Shown to be Effective in TKI Resistant PDX...
-
HP Inc. and Karamba Security extend their XGuard licensing agreement by 3 more years, to harden HP's "the world most secure printers" against cyberattacks
-
Johnstown, PA, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Concurrent Technologies Corporation (CTC) has successfully licensed its patented Metal Injection Molded (MIM) ammunition technology to Ultra Defense...
-
VANCOUVER, British Columbia, Feb. 02, 2026 (GLOBE NEWSWIRE) -- EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today announced that the Company has signed a royalty-bearing...
-
Strategic amendment transforms regional partnership into global collaboration; Newsoara gains exclusive worldwide license to develop and commercialize novel PDE4 inhibitor vTv to receive $20 million...
-
Gameto announces the licensure of IP from Harvard University to genetically induce meiosis in stem cells
-
REYKJAVIK, Iceland, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients...